Biotechnology Stocks I Performance Guide: NewAmsterdam Pharma Company N.V. (NAMS)
NAMS has no dividends.
Table and Chart of NAMS Performance
See what a $1,000 investment in NAMS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NAMS Returns | |
|---|---|
| Start Date | Dec-30-2022 |
| Start Price | $10.90 |
| End Date | Oct-14-2024 |
| End Price | $19.16 |
| # Prices | 23 |
| Min Date | Oct-31-2023 |
| Min Price | $9.00 |
| Max Date | Mar-28-2024 |
| Max Price | $23.65 |
| Total Return | 75.78% |
| Annualized Return | 34.22% |
| Current Value of $1,000 Purchase | $1,758 |
| Number Returns | 253 |
| Average Return | 31.89% |
| Number Profitable Returns | 161 |
| Percent Profitable Returns | 63.64% |
| Number Unprofitable Returns | 92 |
| Percent Unprofitable Returns | 36.36% |
| Profitable to Unprofitable Returns Ratio | 1.75 |
| NAMS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 27.630 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -208628000 |
| PE to Growth Ratio | None |
| Price to Book | 232.31 |
| PRICE DATA | |
| 52 Week High | $0 |
| 52 Week Low | $26.35 |
| Analyst Target Price | $0.327 |
| 50-Day Moving Average | $5.63 |
| 200-Day Moving Average | $16.57 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.62 |
| Revenue | $-1 |
| Profit Margin | 8.5% |
| Return on Equity | -27.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NAMS Compare Returns with S&P 500
NAMS Trendline Chart
NAMS Moving Average Chart
NAMS Stock Return Map - See Patterns of Gains and Losses
NAMS Stock Returns/Purchase Dates